argenx
argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer.
About argenx
argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer.
Company Facts
- Headquarters
- Boston
- Founded
- 2008
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- public
- Employees
- c_01001_05000
- Funding Stage
- ipo
- Total Funding
- $3,753,303,313
- Last Funding Type
- post_ipo_equity
- Last Funding Date
- 2023-07-18
- Website
- argenx.com
Industries & Categories
Biotechnology, Clinical Trials, Therapeutics
Social Links
Canonical: https://fsome.com/organization/argenx-33062 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.